Articoli Scientifici su Riviste Impattate Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine di Redazione Dicembre 5, 2020 scritto da Redazione Dicembre 5, 2020 183 Articolo 0 commento Redazione messaggio precedente Edoxaban nel paziente con fibrillazione atriale e cancro prossimo post Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity Potrebbe piacerti anche “Women survive breast cancer but fall victim to heart failure: the shadows and lights of... Dicembre 5, 2020 “Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience” Dicembre 5, 2020 “Intracardiac metastasis originated from chondrosarcoma” Dicembre 5, 2020 “Complete atrioventricular block in a patient with intracardiac metastases from malignant melanoma” Dicembre 5, 2020 “Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors” Dicembre 5, 2020 “Early identification of left ventricular dysfunction induced by trastuzumab” Dicembre 5, 2020 “Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge” Dicembre 5, 2020 “Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer” Dicembre 5, 2020 “Administration of angiotensin-coverting enzyme inhibitors and B-blockers during adjuvant trastuzumab chemotherapy for nonmetastatic breast cancer:... Dicembre 5, 2020 “Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a... Dicembre 5, 2020
